1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Transplantation Market, By Product
5.1 Introduction
5.2 Preservation Solutions
5.3 Tissue Products
5.4 Immunosuppressive Drugs
5.5 Other Products
6 Global Transplantation Market, By Application
6.1 Introduction
6.2 Tissue Transplant
6.3 Organ Transplant
6.4 Other Applications
7 Global Transplantation Market, By End User
7.1 Introduction
7.2 Transplantation Centers
7.3 Hospitals
7.4 Other End Users
8 Global Transplantation Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Novartis AG
10.2 21 st Century Medicine
10.3 Stryker Corporation
10.4 TransMedics
10.5 Zimmer Biomet
10.6 Astellas Pharma Inc
10.7 Medtronic
10.8 AbbVie Inc
10.9 Biolife Solutions
10.10 Teva Pharmaceutical
10.11 Veloxis Pharmaceuticals Inc
10.12 Abbott
10.13 Becton, Dickinson and Company (BD)
10.14 BioMérieux SA
10.15 Bio-Rad Laboratories Inc
10.16 CareDx Inc
10.17 F. Hoffmann-La Roche Ltd
10.18 Hologic Inc
10.19 Illumina Inc
10.20 QIAGEN
10.21 Arthrex Inc
List of Tables
Table 1 Global Transplantation Market Outlook, By Region (2020-2028) ($MN)
Table 2 Global Transplantation Market Outlook, By Product (2020-2028) ($MN)
Table 3 Global Transplantation Market Outlook, By Preservation Solutions (2020-2028) ($MN)
Table 4 Global Transplantation Market Outlook, By Tissue Products (2020-2028) ($MN)
Table 5 Global Transplantation Market Outlook, By Immunosuppressive Drugs (2020-2028) ($MN)
Table 6 Global Transplantation Market Outlook, By Other Products (2020-2028) ($MN)
Table 7 Global Transplantation Market Outlook, By Application (2020-2028) ($MN)
Table 8 Global Transplantation Market Outlook, By Tissue Transplant (2020-2028) ($MN)
Table 9 Global Transplantation Market Outlook, By Organ Transplant (2020-2028) ($MN)
Table 10 Global Transplantation Market Outlook, By Other Applications (2020-2028) ($MN)
Table 11 Global Transplantation Market Outlook, By End User (2020-2028) ($MN)
Table 12 Global Transplantation Market Outlook, By Transplantation Centers (2020-2028) ($MN)
Table 13 Global Transplantation Market Outlook, By Hospitals (2020-2028) ($MN)
Table 14 Global Transplantation Market Outlook, By Other End Users (2020-2028) ($MN)
Table 15 North America Transplantation Market Outlook, By Country (2020-2028) ($MN)
Table 16 North America Transplantation Market Outlook, By Product (2020-2028) ($MN)
Table 17 North America Transplantation Market Outlook, By Preservation Solutions (2020-2028) ($MN)
Table 18 North America Transplantation Market Outlook, By Tissue Products (2020-2028) ($MN)
Table 19 North America Transplantation Market Outlook, By Immunosuppressive Drugs (2020-2028) ($MN)
Table 20 North America Transplantation Market Outlook, By Other Products (2020-2028) ($MN)
Table 21 North America Transplantation Market Outlook, By Application (2020-2028) ($MN)
Table 22 North America Transplantation Market Outlook, By Tissue Transplant (2020-2028) ($MN)
Table 23 North America Transplantation Market Outlook, By Organ Transplant (2020-2028) ($MN)
Table 24 North America Transplantation Market Outlook, By Other Applications (2020-2028) ($MN)
Table 25 North America Transplantation Market Outlook, By End User (2020-2028) ($MN)
Table 26 North America Transplantation Market Outlook, By Transplantation Centers (2020-2028) ($MN)
Table 27 North America Transplantation Market Outlook, By Hospitals (2020-2028) ($MN)
Table 28 North America Transplantation Market Outlook, By Other End Users (2020-2028) ($MN)
Table 29 Europe Transplantation Market Outlook, By Country (2020-2028) ($MN)
Table 30 Europe Transplantation Market Outlook, By Product (2020-2028) ($MN)
Table 31 Europe Transplantation Market Outlook, By Preservation Solutions (2020-2028) ($MN)
Table 32 Europe Transplantation Market Outlook, By Tissue Products (2020-2028) ($MN)
Table 33 Europe Transplantation Market Outlook, By Immunosuppressive Drugs (2020-2028) ($MN)
Table 34 Europe Transplantation Market Outlook, By Other Products (2020-2028) ($MN)
Table 35 Europe Transplantation Market Outlook, By Application (2020-2028) ($MN)
Table 36 Europe Transplantation Market Outlook, By Tissue Transplant (2020-2028) ($MN)
Table 37 Europe Transplantation Market Outlook, By Organ Transplant (2020-2028) ($MN)
Table 38 Europe Transplantation Market Outlook, By Other Applications (2020-2028) ($MN)
Table 39 Europe Transplantation Market Outlook, By End User (2020-2028) ($MN)
Table 40 Europe Transplantation Market Outlook, By Transplantation Centers (2020-2028) ($MN)
Table 41 Europe Transplantation Market Outlook, By Hospitals (2020-2028) ($MN)
Table 42 Europe Transplantation Market Outlook, By Other End Users (2020-2028) ($MN)
Table 43 Asia Pacific Transplantation Market Outlook, By Country (2020-2028) ($MN)
Table 44 Asia Pacific Transplantation Market Outlook, By Product (2020-2028) ($MN)
Table 45 Asia Pacific Transplantation Market Outlook, By Preservation Solutions (2020-2028) ($MN)
Table 46 Asia Pacific Transplantation Market Outlook, By Tissue Products (2020-2028) ($MN)
Table 47 Asia Pacific Transplantation Market Outlook, By Immunosuppressive Drugs (2020-2028) ($MN)
Table 48 Asia Pacific Transplantation Market Outlook, By Other Products (2020-2028) ($MN)
Table 49 Asia Pacific Transplantation Market Outlook, By Application (2020-2028) ($MN)
Table 50 Asia Pacific Transplantation Market Outlook, By Tissue Transplant (2020-2028) ($MN)
Table 51 Asia Pacific Transplantation Market Outlook, By Organ Transplant (2020-2028) ($MN)
Table 52 Asia Pacific Transplantation Market Outlook, By Other Applications (2020-2028) ($MN)
Table 53 Asia Pacific Transplantation Market Outlook, By End User (2020-2028) ($MN)
Table 54 Asia Pacific Transplantation Market Outlook, By Transplantation Centers (2020-2028) ($MN)
Table 55 Asia Pacific Transplantation Market Outlook, By Hospitals (2020-2028) ($MN)
Table 56 Asia Pacific Transplantation Market Outlook, By Other End Users (2020-2028) ($MN)
Table 57 South America Transplantation Market Outlook, By Country (2020-2028) ($MN)
Table 58 South America Transplantation Market Outlook, By Product (2020-2028) ($MN)
Table 59 South America Transplantation Market Outlook, By Preservation Solutions (2020-2028) ($MN)
Table 60 South America Transplantation Market Outlook, By Tissue Products (2020-2028) ($MN)
Table 61 South America Transplantation Market Outlook, By Immunosuppressive Drugs (2020-2028) ($MN)
Table 62 South America Transplantation Market Outlook, By Other Products (2020-2028) ($MN)
Table 63 South America Transplantation Market Outlook, By Application (2020-2028) ($MN)
Table 64 South America Transplantation Market Outlook, By Tissue Transplant (2020-2028) ($MN)
Table 65 South America Transplantation Market Outlook, By Organ Transplant (2020-2028) ($MN)
Table 66 South America Transplantation Market Outlook, By Other Applications (2020-2028) ($MN)
Table 67 South America Transplantation Market Outlook, By End User (2020-2028) ($MN)
Table 68 South America Transplantation Market Outlook, By Transplantation Centers (2020-2028) ($MN)
Table 69 South America Transplantation Market Outlook, By Hospitals (2020-2028) ($MN)
Table 70 South America Transplantation Market Outlook, By Other End Users (2020-2028) ($MN)
Table 71 Middle East & Africa Transplantation Market Outlook, By Country (2020-2028) ($MN)
Table 72 Middle East & Africa Transplantation Market Outlook, By Product (2020-2028) ($MN)
Table 73 Middle East & Africa Transplantation Market Outlook, By Preservation Solutions (2020-2028) ($MN)
Table 74 Middle East & Africa Transplantation Market Outlook, By Tissue Products (2020-2028) ($MN)
Table 75 Middle East & Africa Transplantation Market Outlook, By Immunosuppressive Drugs (2020-2028) ($MN)
Table 76 Middle East & Africa Transplantation Market Outlook, By Other Products (2020-2028) ($MN)
Table 77 Middle East & Africa Transplantation Market Outlook, By Application (2020-2028) ($MN)
Table 78 Middle East & Africa Transplantation Market Outlook, By Tissue Transplant (2020-2028) ($MN)
Table 79 Middle East & Africa Transplantation Market Outlook, By Organ Transplant (2020-2028) ($MN)
Table 80 Middle East & Africa Transplantation Market Outlook, By Other Applications (2020-2028) ($MN)
Table 81 Middle East & Africa Transplantation Market Outlook, By End User (2020-2028) ($MN)
Table 82 Middle East & Africa Transplantation Market Outlook, By Transplantation Centers (2020-2028) ($MN)
Table 83 Middle East & Africa Transplantation Market Outlook, By Hospitals (2020-2028) ($MN)
Table 84 Middle East & Africa Transplantation Market Outlook, By Other End Users (2020-2028) ($MN)
| ※参考情報 移植とは、ある生体から組織や臓器を採取し、それを別の個体に移す手法のことを指します。移植は、医療の分野において非常に重要な役割を果たしており、人間や動物において様々な症状や疾病の治療に利用されています。 移植には主に二つの種類があり、自己移植と他家移植に分けられます。自己移植は、同じ個体内での組織や臓器の移動を指し、例えば皮膚や筋肉などが挙げられます。他家移植は、他の個体から組織や臓器を移動させるもので、ヒトからヒトへの移植が一般的です。他家移植には更に、親族からの移植や、ドナーが全くの他人である場合も含まれます。 移植の用途としては、臓器不全や重篤な疾患に対する治療が挙げられます。例えば、腎不全や肝不全、心疾患などに対する腎臓移植や肝臓移植、心臓移植は一般的です。また、重度のやけどや外傷に対して皮膚移植が行われることもあります。移植により患者の生活の質が向上し、治療効果が期待されます。 移植に伴う重要な問題の一つは、拒絶反応のリスクです。他家移植では、移植された組織や臓器が受け取った個体の免疫系によって異物として認識され、拒絶反応が引き起こされることがあります。これに対処するため、移植を受ける患者は、免疫抑制剤を服用する必要があります。これにより、拒絶反応を抑えることができますが、同時に感染症のリスクが高まるという副作用もあります。 最近の研究では、再生医療が移植に関連する新たな可能性として注目されています。再生医療は、患者自身の細胞を用いて損傷した組織や臓器を修復・再生する手法です。この技術は、移植の必要性を減少させ、拒絶反応のリスクを低くするための手段として期待されています。また、バイオロジカル・プリンティング技術の発展により、組織や臓器の人工的な生成も研究が進められています。 さらに、臓器のサイボーグ化技術も進化しています。この技術は、臓器の機能を補完するために、ペースメーカーや補助人工心臓といったデバイスを使用します。これにより、移植が難しい患者に対しても、新たな治療の選択肢が提供されています。 倫理的な観点からも、移植には様々な議論があります。ドナーからの臓器提供の同意や、臓器売買の問題、ドナー不足の解決策など、倫理的に配慮が必要なテーマが多く存在します。また、移植に関する法律や制度も各国で異なっており、国際的な合意形成が求められています。 移植医療は急速に発展を遂げており、その成果として多数の命が救われています。しかし、まだ多くの課題も残されており、今後も研究や技術革新、制度改革が求められる分野です。移植は、医療の未来において重要な位置を占める技術であり、多くの患者に希望を与える可能性を持っています。 |
